OMass Therapeutics

OMass Therapeutics

Biotechnology Research

Oxford, Select... 5,676 followers

About us

OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona Ltd and Oxford Science Enterprises.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Oxford, Select...
Type
Privately Held
Founded
2016

Locations

  • Primary

    Building 4000, Chancellor Court, John Smith Drive

    ARC Oxford

    Oxford, Select... OX4 2GX, GB

    Get directions

Employees at OMass Therapeutics

Updates

Similar pages

Browse jobs

Funding

OMass Therapeutics 5 total rounds

Last Round

Series B

US$ 12.5M

See more info on crunchbase